Outcomes
ADVERSE EVENTS
The primary outcome measures included changes in serum calcium (mg/dL), serum phosphorous (mEq/L) and parathyroid hormone (pg/mL) over time. Rate of changes of alkaline phosphatase (ALP) (U/L) and calcium-phosphorous product (mgSafety outcomes included all serious adverse events and adverse events.